Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Charles Quesenberry and Marilyn Kwan.
Charles Quesenberry
Connection Strength
2.453
Marilyn Kwan
  1. The Influence of Dietary Isothiocyanates on the Effectiveness of Mitomycin C and Bacillus Calmette-Gu?rin in Treating Nonmuscle-Invasive Bladder Cancer. J Urol. 2024 Sep; 212(3):420-430.
    View in: PubMed
    Score: 0.247
  2. Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study. Cancer. 2023 Aug 09.
    View in: PubMed
    Score: 0.233
  3. A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting. J Cancer Surviv. 2021 Feb 09.
    View in: PubMed
    Score: 0.196
  4. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.158
  5. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study. Breast Cancer Res Treat. 2016 08; 159(1):119-29.
    View in: PubMed
    Score: 0.143
  6. RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741. J Natl Cancer Inst. 2016 Jan; 108(1).
    View in: PubMed
    Score: 0.138
  7. RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741. J Natl Cancer Inst. 2015 Jan; 108(1).
    View in: PubMed
    Score: 0.136
  8. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.131
  9. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.131
  10. Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
    View in: PubMed
    Score: 0.127
  11. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
    View in: PubMed
    Score: 0.104
  12. Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
    View in: PubMed
    Score: 0.102
  13. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
    View in: PubMed
    Score: 0.091
  14. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
    View in: PubMed
    Score: 0.081
  15. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
    View in: PubMed
    Score: 0.077
  16. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol. 2017 Mar 01; 3(3):351-357.
    View in: PubMed
    Score: 0.037
  17. Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer. J Clin Oncol. 2016 Oct 20; 34(30):3664-3671.
    View in: PubMed
    Score: 0.036
  18. Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
    View in: PubMed
    Score: 0.036
  19. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
    View in: PubMed
    Score: 0.035
  20. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.030
  21. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
    View in: PubMed
    Score: 0.030
  22. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
    View in: PubMed
    Score: 0.030
  23. Social networks, social support, and burden in relationships, and mortality after breast cancer diagnosis in the Life After Breast Cancer Epidemiology (LACE) study. Breast Cancer Res Treat. 2013 Jan; 137(1):261-71.
    View in: PubMed
    Score: 0.028
  24. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2012 Aug; 21(8):1260-71.
    View in: PubMed
    Score: 0.027
  25. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer. 2012 Apr 15; 118(8):2048-58.
    View in: PubMed
    Score: 0.026
  26. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2009 Nov; 118(2):395-405.
    View in: PubMed
    Score: 0.021
  27. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):87-95.
    View in: PubMed
    Score: 0.021

© 2024 Kaiser Permanente